Premium
Induction of general anaesthesia by effect‐site target‐controlled infusion of propofol: influence of pharmacokinetic model and k e0 value
Author(s) -
Thomson A. J.,
Morrison G.,
Thomson E.,
Beattie C.,
Nimmo A. F.,
Glen J. B.
Publication year - 2014
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/anae.12597
Subject(s) - medicine , propofol , anesthesia , pharmacokinetics , target controlled infusion , blood pressure , remifentanil
Summary We studied the use of a new k e0 value (0.6 min −1 ) for the Marsh pharmacokinetic model for propofol. Speed of induction and side‐effects produced were compared with three other target‐controlled infusion systems. Eighty patients of ASA physical status 1–2 were studied in four groups in a prospective, randomised study. Median (IQR [range]) induction times were shorter with the Marsh model in effect‐site control mode with a k e0 of either 0.6 min −1 (81 (61–101 [49–302])s, p < 0.01), or 1.2 min −1 (78 (68–208 [51–325])s, p < 0.05), than with the Marsh model in blood concentration control (132 (90–246 [57–435])). The Schnider model in effect‐site control produced induction times that were longer (298 (282–398 [58–513])s) than those observed with the Marsh model in blood control (p < 0.05), or either effect‐site control mode (p < 0.001). There were no differences in the magnitude of blood pressure changes or frequency of apnoea between groups.